Krastm4.1Cmco
Targeted Allele Detail
|
Symbol: |
Krastm4.1Cmco |
Name: |
Kirsten rat sarcoma viral oncogene homolog; targeted mutation 4.1, Christopher M Counter |
MGI ID: |
MGI:7432936 |
Synonyms: |
KrasLSL-natQ61R |
Gene: |
Kras Location: Chr6:145162425-145195965 bp, - strand Genetic Position: Chr6, 77.37 cM, cytoband G2
|
Alliance: |
Krastm4.1Cmco page
|
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutations: |
|
Insertion, Single point mutation
|
|
|
Mutation details: Exons 2-4 were replaced by a cassette consisting of a transcriptional repressor sequence (STOP) flanked by loxP sites, cDNA sequence for the first three coding exons (2-4) using native rare codons and including the p.Q61R oncogenic mutation, followed by the 5' 564 bp of intron 4, and an FRT site flanked neomycin resistance gene cassette. The neo cassette was removed via Flp-mediated recombination. Removal of the stop cassette is required to get expression of the mutant Kras at low level due to utilization of the native rare codons.
(J:328899)
|
|
|
|
|
Original: |
J:328899 Le Roux O, et al., Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis. Elife. 2022 Sep 7;11:e75715 |
All: |
1 reference(s) |
|